The interactive fantasy e-book Revealing the Secrets of aHUSputs young children at the centre of the story as they explore and learn with their families about atypical Haemolytic Uraemic Syndrome (aHU ...

Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a $753 million hit for abandoning one of the drugs from that ...

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...

AstraZeneca’s Alexion, which recently announced the building of a new rare disease development hub in Barcelona, is focused mostly on disorders of the complement system, a component of the ...

Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” deal for the pharma. AstraZeneca on Thursday revealed it has discontinued the ...

Shares of the British-Swedish pharmaceutical titan AstraZeneca are trading 7% lower in London today as investors price in the acquisition of Alexion Pharmaceuticals for $39 billion. A deal, which is ...

Efzimfotase alfa is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Hypophosphatasia. According to GlobalData, Phase III drugs for Hypophosphatasia have a 100% ...

Alexion Pharmaceuticals v Amgen (UPC_Coa-405/2024) and Alexion Pharmaceuticals v Samsung Bioepis NL BV (UPC_CoA-402/2024); December 20, 2024. The UPC Court of Appeal has confirmed a strict ...

Spendesk, the leading spend management and procurement platform for mid-market companies, announces the appointment of Alfonso Marone as Executive Chairman of the Board. This strategic governance ...

What are the best building games on PC? Building games are a great way to indulge architectural creativity, but there are many great building games on PC to choose from. Thankfully, we have the ...

As­traZeneca has ter­mi­nat­ed all de­vel­op­ment of vemir­co­pan, the oral fac­tor D in­hibitor it ac­quired through the deal for Alex­ion in 2021. The UK ma­jor record­ed … ...